Dermatology NewsVEXAS syndrome: More common, variable, and severe than expectedJanuary 24, 2023Rare Diseases
Dermatology NewsMastocytosis: Rare, underdiagnosed, potentially fatalJanuary 24, 2023Mixed TopicsRare Diseases
Dermatology NewsNew PDT therapy for CTCL to be reviewed by FDADecember 22, 2022Rare DiseasesMedical Dermatology
Dermatology NewsHave you heard of VEXAS syndrome?December 12, 2022Mixed TopicsRare DiseasesMedical Dermatology
Dermatology NewsCombination therapy shows mixed results for scleroderma-related lung diseaseNovember 15, 2022Rare DiseasesAutoimmune Diseases
Dermatology NewsFirst recommendations for cancer screening in myositis issuedNovember 12, 2022Autoimmune DiseasesRare Diseases
Acquired Acrodermatitis Enteropathica in an InfantNovember 4, 2022PediatricsDermatopathologyRare Diseases
Dermatology NewsNORD Rare Disease Centers of Excellence: A new network seeks to break down barriers in rare disease careOctober 15, 2022Rare Diseases
Dermatology NewsCombination of energy-based treatments found to improve Becker’s neviOctober 13, 2022Dermatologic SurgeryPigmentation DisordersMedical DermatologyRare Diseases
Dermatology NewsIVIG proves effective for dermatomyositis in phase 3 trialOctober 11, 2022Autoimmune DiseasesRare Diseases
Dermatology NewsUncombable hair syndrome: One gene, variants responsible for many casesSeptember 20, 2022Hair & NailsPediatricsRare Diseases
Dermatology NewsFDA okays spesolimab, first treatment for generalized pustular psoriasisSeptember 2, 2022PsoriasisRare Diseases
Dermatology NewsBiosimilar-to-biosimilar switches deemed safe and effective, systematic review revealsAugust 15, 2022Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
Dermatology NewsUstekinumab becomes second biologic approved for PsA in kidsAugust 3, 2022Psoriatic ArthritisPediatricsRare Diseases
